The cost of drug development: A systematic review

作者: Steve Morgan , Paul Grootendorst , Joel Lexchin , Colleen Cunningham , Devon Greyson

DOI: 10.1016/J.HEALTHPOL.2010.12.002

关键词: CitationActuarial scienceTransparency (graphic)Drug developmentMedicinePharmaceutical industryMEDLINECost estimateAuditCashOperations management

摘要: … We sought English language research articles on the cost of drug development that were … the evidence generated from studies of the cost of new drug research and development. …

参考文章(14)
Joseph A. Dimasi, Henry G. Grabowski, John Vernon, R&d Costs, Innovative Output and Firm Size in the Pharmaceutical Industry International Journal of The Economics of Business. ,vol. 2, pp. 201- 219 ,(1995) , 10.1080/758519309
Joseph A. DiMasi, Henry G. Grabowski, The cost of biopharmaceutical R&D: is biotech different? Managerial and Decision Economics. ,vol. 28, pp. 469- 479 ,(2007) , 10.1002/MDE.1360
Henry G Grabowski, John M Vernon, Returns to R&D on new drug introductions in the 1980s Journal of Health Economics. ,vol. 13, pp. 383- 406 ,(1994) , 10.1016/0167-6296(94)90010-8
Robert I. Chien, Issues in pharmaceutical economics ,(1979)
Joseph A. DiMasi, Ronald W. Hansen, Henry G. Grabowski, Louis Lasagna, Research and development costs for new drugs by therapeutic category. A study of the US pharmaceutical industry. PharmacoEconomics. ,vol. 7, pp. 152- 169 ,(1995) , 10.2165/00019053-199507020-00007
Joseph A DiMasi, Ronald W Hansen, Henry G Grabowski, The price of innovation: new estimates of drug development costs Journal of Health Economics. ,vol. 22, pp. 151- 185 ,(2003) , 10.1016/S0167-6296(02)00126-1
Donald W. Light, Rebecca N. Warburton, Extraordinary claims require extraordinary evidence. Journal of Health Economics. ,vol. 24, pp. 1030- 1033 ,(2005) , 10.1016/J.JHEALECO.2005.07.001
Joseph A. DiMasi, Henry G. Grabowski, John Vernon, R&D Costs and Returns by Therapeutic Category Drug Information Journal. ,vol. 38, pp. 211- 223 ,(2004) , 10.1177/009286150403800301
Joseph A DiMasi, Ronald W Hansen, Henry G Grabowski, Louis Lasagna, Cost of innovation in the pharmaceutical industry. Journal of Health Economics. ,vol. 10, pp. 107- 142 ,(1991) , 10.1016/0167-6296(91)90001-4